Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-d-tryptophan-luteinizing Hormone-releasing Factor (pig)
2. Ay 25650
3. Ay-25650
4. Ay25650
5. Cl 118532
6. Cl-118532
7. Cl118532
8. D-trp-6-lh-rh
9. Decapeptyl
10. Decapeptyl Depot
11. Decapeptyl Lp
12. Decapeptyl Trimestral
13. Embonate, Triptorelin
14. Gnrh, Trp(6)-
15. Lhrh, Trp(6)-
16. Lhrh, Tryptophyl(6)-
17. Pamoate, Triptorelin
18. Trelstar
19. Trimestral, Decapeptyl
20. Triptorelin
21. Triptorelin Embonate
22. Triptorelin Pamoate
23. Wy 42462
24. Wy-42462
25. Wy42462
1. 140194-24-7
2. 140194-24-7 (acetate)
3. Bim 21003
4. Wy 42422
5. Wy 42462
6. Ay 25650
7. Pglu-his-trp-ser-tyr-d-trp-leu-arg-pro-gly-nh2 Acetate
8. Decapeptyl (tn)
9. (s)-n-(2-amino-2-oxoethyl)-1-(((s)-5-oxopyrrolidine-2-carbonyl)-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-d-tryptophyl-l-leucyl-l-arginyl)pyrrolidine-2-carboxamide Acetate
10. Unii-43ofw291r9
11. Bim 21003c
12. 43ofw291r9
13. Dtxsid301033427
14. 6-d-tryptophan Luteinizing Hormone-releasing Factor (swine) Acetate
15. Hy-12551a
16. Akos030485974
17. Cs-0012388
18. Propan-2-yl]-5-oxopyrrolidine-2-carboxamide
19. D08649
20. J-007369
21. Q27258659
22. Luteinizing Hormone-releasing Factor (swine), 6-d-tryptophan-, Acetate (1:1)
23. 2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1h-imidazol-4-yl)-1-oxo
24. Acetic Acid;(2s)-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[(2s)-1-[[(2s)-1-[(2s)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-
Molecular Weight | 1371.5 g/mol |
---|---|
Molecular Formula | C66H86N18O15 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 33 |
Exact Mass | 1370.65200411 g/mol |
Monoisotopic Mass | 1370.65200411 g/mol |
Topological Polar Surface Area | 528 Ų |
Heavy Atom Count | 99 |
Formal Charge | 0 |
Complexity | 2750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
For the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
Luteolytic Agents
Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)
QH01CA97
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0007
Start Marketing Date : 2002-03-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
VMF Number : 5948
Submission : 2009-03-26
Status : Active
Type : II
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
CSBio provides high-quality custom peptides, cGMP peptides, automated peptide synthesizers & other instrumentation to biotech industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26391
Submission : 2012-09-05
Status : Active
Type : II
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : Gonapeptyl
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 0.1 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : GONAPEPTYL Depot
Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Dosage Strength : 3.75 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : GONAPEPTYL Depot
Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Dosage Strength : 3.75 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
Reply
17 Oct 2019
Reply
14 Dec 2018
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?